Immunomedics Attacks Investor Proxy Efforts In Del. Suit
Pharmaceutical development company Immunomedics Inc. accused an investor of waging a shadow proxy war for control of the company's board in a suit filed in Delaware federal court Friday, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article